Datasets
Buyer room
GLPCHART.COMManage supplier listing
GLP Chart (Bolvon Pty Ltd) — Two distinct datasets. (A) Weekly-verified US cash-pay GLP-1 telehealth price index: program-by-drug all-in monthly MAINTENANCE prices (not intro tiers) for 33 programs across 7 drugs, with lock-in/commitment terms, a 0-10 score decomposed into five equally-weighted sub-scores, insurance-route copay rows, a month-over-month price-history series, a weekly price-change log, and per-insurer GLP-1 coverage policy reads (15 payors) tied to named policy/formulary documents and read dates. (B) A consented patient-reported real-world GLP-1 outcomes panel capturing drug, d…
supplier index read from their site
Two distinct datasets. (A) Weekly-verified US cash-pay GLP-1 telehealth price index: program-by-drug all-in monthly MAINTENANCE prices (not intro tiers) for 33 programs across 7 drugs, with lock-in/commitment terms, a 0-10 score decomposed into five equally-weighted sub-scores, insurance-route copay rows, a month-over-month price-history series, a weekly price-change log, and per-insurer GLP-1 coverage policy reads (15 payors) tied to named policy/formulary documents and read dates. (B) A consented patient-reported real-world GLP-1 outcomes panel capturing drug, dose, indication, weeks on drug, side-effect ratings, discontinuation intent and nausea management - framed by the publisher as outcomes 'not shown in claims data'.
Coverage Health CareAsset class EquitiesTickers LLY · NVO · HIMS
Sample, licence terms, pricing and eval results when Glpchart publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Glpchart, answered from this page.
GLP Chart (Bolvon Pty Ltd) — Two distinct datasets. (A) Weekly-verified US cash-pay GLP-1 telehealth price index: program-by-drug all-in monthly MAINTENANCE prices (not intro tiers) for 33 programs across 7 drugs, with lock-in/commitment terms, a 0-10 score decomposed into five equally-weighted sub-scores, insurance-route copay rows, a month-over-month price-history series, a weekly price-change log, and per-insurer GLP-1 coverage policy reads (15 payors) tied to named policy/formulary documents and read dates. (B) A consented patient-reported real-world GLP-1 outcomes panel capturing drug, d…
Glpchart offers (Alternative, Fundamental, Sentiment) — Stated current snapshot: 43 verified cash-pay price rows across 33 programs and 7 drugs; 5 sub-scores per program (~165 scored observations); ~550 price observations per year at weekly verification cadence; roughly 500 program-drug rows across 12 monthly index editions for the history series; 15 insurer coverage-policy reads with document numbers and dates; Medicaid state-level listings; a dated weekly change log; a clinical-trial directory; and 36 explainers. Panel (dataset B) volume is a function of the consented roster and monthly check-in cadence - currently undisclosed..
Employer and self-insured plan benefit design and GLP-1 spend forecasting; PBM/pharmacy-benefit formulary and prior-authorization criteria analysis; payer coverage-change impact measurement (the site already quantifies the Massachusetts benefit-drop effect); telehealth competitive pricing and revenue-management benchmarking; consumer-protection and drip-pricing regulatory surveillance using the intro-vs-maintenance gap series; pharma market-access and list-vs-realized price monitoring for branded GLP-1s; real-world-evidence on tolerability, persistence and discontinuation to support label discussions and trial recruitment; ML training for price-extraction and promotional-pricing-detection models using the dated evidence pairs as ground truth.
Coverage spans US; Pharmaceuticals: Drug Makers, Health Care Technology; alternative, fundamental, sentiment; equities.
Glpchart has not added their own details yet. Not yet on file: